Effector Therapeutics Inc Cash Flow Reinvestment Rate

Latest as of June 2020: 0.00x

Effector Therapeutics Inc cash flow reinvestment rate. Effector Therapeutics Inc (EFTR) has a Cash Flow Reinvestment Rate of 0.00x as of June 2020, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $11.98 Million. Explore debt repayment capacity of Effector Therapeutics Inc to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.00x

(Capex + Investments) / Operating CF

Total Reinvested

$0.00

Capex + Investments

Operating Cash Flow

$11.98 Million

USD

Capital Expenditures

$0.00

USD

Cash Flow Reinvestment Rate of Effector Therapeutics Inc (2020–2020)

Cash flow reinvestment rate of Effector Therapeutics Inc from 2020 to 2020. Historical reinvestment intensity for Effector Therapeutics Inc across 1 annual periods. Explore capital reinvestment ratio of Effector Therapeutics Inc to see what proportion of operating cash flow is directed to capital expenditures.

Effector Therapeutics Inc Cash Flow Reinvestment Rate by Year (2020–2020)

Effector Therapeutics Inc cash flow reinvestment rate by year from 2020 to 2020. Year-by-year capital reinvestment analysis for Effector Therapeutics Inc. For the full cash flow conversion analysis, see EFTR cash flow conversion.

Year	Reinvestment Rate	Total Reinvested (USD)	Operating CF	Capex	YoY Change
2020	0.02x	$308.00K	$13.84 Million	$154.00K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow